Giorgio Trinchieri elected to the National Academy of Sciences – NIH IRP
National Institutes of Health (NIH): Intramural Research Program (IRP) shared a post on LinkedIn:
“Dr. Giorgio Trinchieri at the National Cancer Institute (NCI)’s Center for Cancer Research has long stood at the forefront of cancer therapies. This year, he was elected to the National Academy of Sciences for his achievements in studying the immune system and how it might be better leveraged to combat cancer.
More specifically, his work in identifying the mechanisms regulating the activity of certain immune cells and how the environment around a tumor interacts with the immune system to suppress an immune response to the disease.
Read on to learn more about Dr. Trinchieri’s research.”
Source: National Institutes of Health (NIH): Intramural Research Program (IRP)/LinkedIn
Giorgio Trinchieri is the Chief of the Laboratory of Integrative Cancer Immunology at the National Cancer Institute (NCI). His research focuses on the role of inflammation, innate immune responses, and the commensal microbiota in cancer development, progression, and treatment.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023